Pancreatic cyst surveillance imposes low psychological burden.


Journal

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
ISSN: 1424-3911
Titre abrégé: Pancreatology
Pays: Switzerland
ID NLM: 100966936

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 24 04 2019
revised: 23 08 2019
accepted: 30 08 2019
pubmed: 5 10 2019
medline: 16 5 2020
entrez: 5 10 2019
Statut: ppublish

Résumé

For the currently recommended pancreatic cyst surveillance to be feasible, participant adherence is a prerequisite. Our objective was to evaluate the psychological burden of pancreatic cyst surveillance from a participant's perspective. The present participant survey is part of an international cohort study (PACYFIC study, www.pacyfic.net), which prospectively records the outcome of surveillance of asymptomatic pancreatic cysts. Participants are invited to complete questionnaires before and during cyst surveillance. 109 participants, 31 enrolled before and 78 during surveillance (median time since cyst diagnosis 16.5 (IQR 36) months), returned a total of 179 questionnaires. The majority indicated that surveillance reduces concerns of developing pancreatic cancer (82%), gives a sense of certainty (81%) and is a good method to detect cancer (91%). Participants already undergoing surveillance reported more negative aspects than those still to commence, like sleeping worse (30% vs 13%, P = 0.035), postponing plans (32% vs 13%, P = 0.031), and finding the follow-up burdensome (33% vs 13%, P = 0.044). Overall, the vast majority (94%) deemed advantages to outweigh disadvantages. Anxiety and depression scores were low (median Hospital Anxiety and Depression Scale 4 for anxiety (IQR 6), 2 for depression (IQR 5)). The psychological burden of pancreatic cyst surveillance is low. Therefore, participant adherence is expected to be high and annual surveillance seems feasible.

Sections du résumé

BACKGROUND/OBJECTIVES OBJECTIVE
For the currently recommended pancreatic cyst surveillance to be feasible, participant adherence is a prerequisite. Our objective was to evaluate the psychological burden of pancreatic cyst surveillance from a participant's perspective.
METHODS METHODS
The present participant survey is part of an international cohort study (PACYFIC study, www.pacyfic.net), which prospectively records the outcome of surveillance of asymptomatic pancreatic cysts. Participants are invited to complete questionnaires before and during cyst surveillance.
RESULTS RESULTS
109 participants, 31 enrolled before and 78 during surveillance (median time since cyst diagnosis 16.5 (IQR 36) months), returned a total of 179 questionnaires. The majority indicated that surveillance reduces concerns of developing pancreatic cancer (82%), gives a sense of certainty (81%) and is a good method to detect cancer (91%). Participants already undergoing surveillance reported more negative aspects than those still to commence, like sleeping worse (30% vs 13%, P = 0.035), postponing plans (32% vs 13%, P = 0.031), and finding the follow-up burdensome (33% vs 13%, P = 0.044). Overall, the vast majority (94%) deemed advantages to outweigh disadvantages. Anxiety and depression scores were low (median Hospital Anxiety and Depression Scale 4 for anxiety (IQR 6), 2 for depression (IQR 5)).
CONCLUSION CONCLUSIONS
The psychological burden of pancreatic cyst surveillance is low. Therefore, participant adherence is expected to be high and annual surveillance seems feasible.

Identifiants

pubmed: 31582346
pii: S1424-3903(19)30719-7
doi: 10.1016/j.pan.2019.08.011
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1061-1066

Investigateurs

M J Bruno (MJ)
D L Cahen (DL)
P A van Riet (PA)
K A Overbeek (KA)
I J M Levink (IJM)
B Koopmann (B)
M G H Besselink (MGH)
M Del Chiaro (M)
M M Lerch (MM)
M B Wallace (MB)
M van Ballegooijen (M)
K Biermann (K)
E M A Bleiker (EMA)
T H L Bollen (THL)
P Fockens (P)
I M C M de Kok (IMCM)
L H J Looijenga (LHJ)
M P Peppelenbosch (MP)
J H E Verhagen-Oldenampsen (JHE)
P G Arcidiacono (PG)
G Capurso (G)
J Bergmann (J)
A van Berkel (A)
G Beyer (G)
R Bijlsma (R)
H Braat (H)
D L Cahen (DL)
S Carrara (S)
L Czakó (L)
H van Erp-van der Steen (H)
S Ganesh (S)
E van Geenen (E)
T Gonda (T)
C Hoge (C)
P Honkoop (P)
J E van Hooft (JE)
J Jansen (J)
A Larghi (A)
I van Leeuwenburgh (I)
J Laukkarinen (J)
N Lelyveld (N)
M Lerch (M)
M C di Marco (MC)
C Ricci (C)
R Casadei (R)
E P Rau (EP)
L Perk (L)
M Polkowski (M)
A Pukitits (A)
R Quispel (R)
D Radenkovic (D)
A Seicean (A)
T Schwartz (T)
E J Schoon (EJ)
E van Soest (E)
A Tan (A)
N G Venneman (NG)
P Vos (P)
A Voorburg (A)
L A van der Waaij (LA)
M B Wallace (MB)
L R H Wijkerslooth (LRH)
G Zerboni (G)
G Capurso (G)
G Della Fave (G)
B Zonderhuis (B)

Informations de copyright

Copyright © 2019 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Auteurs

Kasper A Overbeek (KA)

Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands. Electronic address: k.overbeek@erasmusmc.nl.

Anne Kamps (A)

Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.

Priscilla A van Riet (PA)

Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.

Mariacristina Di Marco (M)

Department of Specialized, Experimental and Diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Giulia Zerboni (G)

Digestive and Liver Disease Unit, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Jeanin E van Hooft (JE)

Department of Gastroenterology & Hepatology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Silvia Carrara (S)

Department of Gastroenterology, Digestive Endoscopy Unit, Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy.

Claudio Ricci (C)

Department of Medical Science and Surgery, Alma Mater Studiorum-University of Bologna, Bologna, Italy.

Tamas A Gonda (TA)

Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York, USA.

Erik Schoon (E)

Department of Gastroenterology & Hepatology, Catharina Hospital, Eindhoven, the Netherlands.

Marcin Polkowski (M)

Department of Gastroenterological Oncology, The M. Skłodowska-Curie Memorial Cancer Centre, Warsaw, Poland; Department of Gastroenterology, Center of Postgraduate Medical Education, Warsaw, Poland.

Georg Beyer (G)

Department of Medicine II, University Hospital, LMU Munich, Germany.

Pieter Honkoop (P)

Department of Gastroenterology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.

Laurens A van der Waaij (LA)

Department of Gastroenterology & Hepatology, Martini Hospital, Groningen, the Netherlands.

Riccardo Casadei (R)

Department of Specialized, Experimental and Diagnostic Medicine, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Gabriele Capurso (G)

Digestive and Liver Disease Unit, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy; PancreatoBiliary Endoscopy and EUS Division, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute IRCCS, Milan, Italy.

Nicole S Erler (NS)

Department of Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands.

Marco J Bruno (MJ)

Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.

Eveline M A Bleiker (EMA)

Division of Psychosocial Research and Epidemiology & Family Cancer Clinic, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Djuna L Cahen (DL)

Department of Gastroenterology & Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH